
Look at any country or region with a strong generic pharmaceutical and active ingredient manufacturing sector, and you are sure …
Life Sciences companies across Europe are facing a series of emerging global legislation and increased regulatory enforcement, designed to prevent …
European pharma companies will face major challenges over the next three years implementing new regulatory legislation and compliance requirements, according …
Regulation! Regulation! Regulation! Never has our business been more highly regulated than it is today. Seemingly, rules change every day. …
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board

